Advancing Topical Therapeutics

In this book you have know the development of a gel-loaded microsponge system encapsulating 18-β glycyrrhetinic acid represents a significant advancement in topical therapeutics. The optimized formulation demonstrated excellent anti-inflammatory activity, stability, and patient-friendly properties. By targeting TNF-α-mediated inflammation, this innovative delivery system holds promise for treating various dermatological conditions with improved efficacy and safety. Future studies could focus on clinical trials to validate these findings and explore the potential of microsponge technology for other bioactive compounds.